NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis
The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

NCT04368663

RecruitingNA

Sponsor: Showa Inan General Hospital

Conditions: Pneumatosis Cystoides Intestinalis

Interventions: Japanese traditional medicine group

Countries: Japan

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa

Exclusion Criteria:

* patients can not take Keishi-ka-shakuyaku-daio-to(TJ-134)
Locations (1)
  • Komagane, Nagano, Japan